BB Biotech Financial Statements From 2010 to 2026
BB Biotech's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing BB Biotech's valuation are provided below:BB Biotech AG does not at this moment have any fundamental measures for analysis.
This module can also supplement various BB Biotech Technical models . Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc etf could be closely tied with the direction of predictive economic indicators such as signals in census.
Check BB Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BB Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . BBAGF financial statements analysis is a perfect complement when working with BB Biotech Valuation or Volatility modules.
BBAGF |
BB Biotech AG OTC Etf Beta Analysis
BB Biotech's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current BB Biotech Beta | 0.96 |
Most of BB Biotech's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BB Biotech AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, BB Biotech AG has a Beta of 0.96. This is much higher than that of the family and significantly higher than that of the Beta category. The beta for all United States etfs is notably lower than that of the firm.
BB Biotech AG Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BB Biotech's current stock value. Our valuation model uses many indicators to compare BB Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BB Biotech competition to find correlations between indicators driving BB Biotech's intrinsic value. More Info.BB Biotech AG is third largest ETF in price to earning as compared to similar ETFs. It is second largest ETF in price to book as compared to similar ETFs fabricating about 0.23 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for BB Biotech AG is roughly 4.38 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BB Biotech's earnings, one of the primary drivers of an investment's value.Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc etf could be closely tied with the direction of predictive economic indicators such as signals in census. Note that the BB Biotech AG information on this page should be used as a complementary analysis to other BB Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in BBAGF OTC Etf
If you are still planning to invest in BB Biotech AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BB Biotech's history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |